-
Signature
-
/s/ Vincent Fontanilla, Attorney-in-Fact
-
Issuer symbol
-
NTRA
-
Transactions as of
-
22 Oct 2025
-
Net transactions value
-
-$412,951
-
Form type
-
4
-
Filing time
-
24 Oct 2025, 21:35:04 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Brophy Michael Burkes |
CHIEF FINANCIAL OFFICER |
C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN |
/s/ Vincent Fontanilla, Attorney-in-Fact |
24 Oct 2025 |
0001697362 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
NTRA |
Common Stock |
Sale |
$171,746 |
-920 |
-1.3% |
$186.68 |
69,189 |
22 Oct 2025 |
Direct |
F1 |
| transaction |
NTRA |
Common Stock |
Options Exercise |
|
+1,250 |
+1.8% |
|
70,439 |
22 Oct 2025 |
Direct |
F2 |
| transaction |
NTRA |
Common Stock |
Sale |
$92,644 |
-495 |
-0.7% |
$187.16 |
69,944 |
23 Oct 2025 |
Direct |
F3 |
| transaction |
NTRA |
Common Stock |
Sale |
$148,561 |
-755 |
-1.1% |
$196.77 |
69,189 |
24 Oct 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
NTRA |
Restricted Stock Unit |
Options Exercise |
$0 |
-1,250 |
-100% |
$0.000000 |
0 |
22 Oct 2025 |
Common Stock |
1,250 |
|
Direct |
F2, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: